Search Results
Apr 24, 2026, 14:25 ET TCL realiza Conferência Global de Parceiros 2026, anuncia lançamentos, apresenta estratégia de inovação e destaca forte crescimento
consumo e a marca nº 1 do mundo em TVs Mini LED e de telas ultragrandes1, realizou a Conferência Global de Parceiros da TCL Industries 2026 (GPC 2026), em Shenzhen. Realizado sob o tema "Pioneering for Greatness" (Pioneirismo para Excelência), o encontro bienal reuniu cerca de 500 clientes estratégicos,
More news about: TCL
Apr 24, 2026, 14:25 ET TCL Industries organiza la Conferencia Global de Socios 2026, presentando su última hoja de ruta y estrategia de innovación mientras atraviesa un fuerte crecimiento
la marca número 1 del mundo en Mini LED y televisores ultragrandes1, ha acogido hoy la Conferencia Global Partners de TCL Industries 2026 (GPC 2026) en Shenzhen. Celebrada bajo el lema "Pioneros para la Grandeza", la reunión bienal reunió a casi 500 cuentas clave, socios estratégicos
More news about: TCL
Apr 21, 2026, 23:51 ET /C O R R E C T I O N -- TCL/
consumer electronics and the world's No. 1 Mini LED and ultra-large TV brand[1], today hosted the 2026 TCL Industries Global Partners Conference (GPC 2026) in Shenzhen. Held under the theme "Pioneering for Greatness," the biennial gathering brought together nearly 500 key accounts, strategic
More news about: TCL
Apr 21, 2026, 06:55 ET Genuine Parts Company Reports First Quarter 2026 Results and Reaffirms Full-Year Outlook
ATLANTA, April 21, 2026 /PRNewswire/ -- Genuine Parts Company (NYSE: GPC), a leading global service provider of automotive and industrial replacement parts and value-added solutions, announced today its results for the first
More news about: Genuine Parts Company
Apr 17, 2026, 09:00 ET Parker Institute for Cancer Immunotherapy Network Shapes the Future Of Immunotherapy with Latest Research at AACR Annual Meeting 2026
Abstract 1351); targeting the oncofetal antigen GPC2 in medulloblastoma (
More news about: Parker Institute for Cancer Immunotherapy
Apr 09, 2026, 20:00 ET Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
company has built a differentiated portfolio that positions it at the vanguard of the global CAR-T race.OriCell's lead asset, Ori-C101, is a GPC3-targeted autologous CAR-T therapy for advanced hepatocellular carcinoma (HCC). Having successfully navigated investigator-initiated trials (IIT) and
More news about: Oricell Therapeutics Holdings Limited
Apr 07, 2026, 08:00 ET Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
across 18 brain regions. The five metabolites analyzed were: total creatine (Cr+PCr), glutamate (Glu), glycerophosphocholine plus phosphocholine (GPC+PCh), myo-inositol (Ins), and N-acetylaspartate plus N-acetylaspartylglutamate (NAA+NAAG). Statistical analyses used the Wilcoxon signed-rank test and
More news about: Alzamend Neuro, Inc.
Apr 03, 2026, 14:42 ET NNB Nutrition Powers Next Generation of Functional Beverages with GeniusPure™, Featured in New Launches from Update, Bucked Up, and Life Cider X
ingredient solutions, today announced its role in powering a new wave of ready-to-drink (RTD) beverages featuring GeniusPure™, its premium alpha-GPC ingredient known for enhancing cognitive performance. These launches include high-profile collaborations and cutting-edge formulations from Update,
More news about: NNB Nutrition
Mar 31, 2026, 08:30 ET Genuine Parts Company to Report First Quarter 2026 Results on April 21, 2026
ATLANTA, March 31, 2026 /PRNewswire/ -- Genuine Parts Company (NYSE: GPC), a leading global service provider of automotive and industrial replacement parts and value-added solutions, plans to release first quarter financial
More news about: Genuine Parts Company
Mar 26, 2026, 09:54 ET Keymed Biosciences Announces 2025 Annual Results and Business Updates
asthma completed enrollment of the first subject in March 2026, and a Phase III clinical study for CRSwNP was initiated in February 2026.CM350 (GPC3 x CD3 bispecific antibody) : Phase I/II study in advanced solid tumors is in dose-escalation phase.CM369/ICP-B05 (CCR8 antibody) : Phase I
More news about: Keymed
Mar 20, 2026, 12:31 ET Czech Olympian Petr Svoboda Credits Igniton for Help in Setting Masters World Record, Marking Extraordinary Comeback After Severe Injury
resilienceOverall performance readinessThe formulations include ingredients such as Nicotinamide Ribose, Resveratrol, PQQ, Citicoline, Alpha-GPC, NADH and other compounds studied as nootropics and for their role in supporting energy metabolism, recovery and healthy aging.The ingredients
More news about: Gaia
Mar 19, 2026, 17:17 ET Czech Olympian Petr Svoboda Credits Igniton for Help in Setting Masters World Record, Marking Extraordinary Comeback After Severe Injury
resilienceOverall performance readinessThe formulations include ingredients such as Nicotinamide Ribose, Resveratrol, PQQ, Citicoline, Alpha-GPC, NADH and other compounds studied as nootropics and for their role in supporting energy metabolism, recovery and healthy aging.The ingredients
More news about: Igniton Inc.
Mar 17, 2026, 08:26 ET Fox ESS lanceert Intelligent Power Q op Solar Solutions Amsterdam en herdefinieert normen voor energieopslag
bevestigd.Strategische samenwerking verdiepenFox ESS kondigde strategische samenwerkingen aan met verschillende belangrijke distributeurs, waaronder GPC Europe, VDH Power, Koninklijke Oosterberg en OSW. Deze partnerschappen zijn bedoeld om het aanzienlijke potentieel voor energieopslag in de Nederlandse
More news about: Fox ESS
Mar 16, 2026, 01:39 ET Fox ESS lance Intelligent Power Q à Solar Solutions Amsterdam, redéfinissant les normes de stockage
l'énergie.Approfondissement des liens stratégiquesFox ESS a annoncé des collaborations stratégiques avec plusieurs distributeurs clés, dont GPC Europe, VDH Power, Koninklijke Oosterberg et OSW. Ces partenariats visent à libérer un potentiel important pour le stockage de l'énergie sur le marché
More news about: Fox ESS
Mar 15, 2026, 22:56 ET Fox ESS Launches Intelligent Power Q at Solar Solutions Amsterdam, Redefining Storage Standards
storage technology.Deepening Strategic TiesFox ESS announced strategic collaborations with several key distributors, including GPC Europe, VDH Power, Koninklijke Oosterberg, and OSW. These partnerships aim to unlock significant potential for energy storage in the Dutch market and
More news about: Fox ESS
Mar 12, 2026, 10:01 ET Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight
177Lu-NeoB, AAA614, ESP359, 177Lu-PSMA-I&T, Lu-PNT2002, LNTH-1095, FPI-2265, 67CU SAR-BBN, 64Cu-SAR-BBN, 225Ac-PSMA-Trillium, 225Ac-Pelgifatamab, 225Ac-GPC3, ITM-11, 212Pb-NG001, CONV01-α, VMT-α-NET, VMT01, PSV359, CAM-FAP-Ac-225, 225Ac-SSO110, ATT001, NU101, NU201, and others.Discover
More news about: DelveInsight Business Research, LLP
Feb 25, 2026, 08:30 ET Genuine Parts Company to Present at the UBS Global Consumer and Retail Conference
ATLANTA, Feb. 25, 2026 /PRNewswire/ -- Genuine Parts Company (NYSE: GPC), a leading global service provider of automotive and industrial replacement parts and value-added solutions, announced today that Bert Nappier, EVP &
More news about: Genuine Parts Company
Feb 24, 2026, 10:28 ET CPSC Warns Consumers to Immediately Stop Using Gourmia Pressure Cookers Due to Serious Burn Hazard, Multiple Burn Injuries Reported; Majority Sold at Best Buy
quarts, stainless steel and black plastic finishes, a pressure lid, a digital temperature and function display, and button controls. The model number is GPC625.These products were manufactured in China.CPSC urges consumers to stop using the pressure cookers immediately and
More news about: U.S. Consumer Product Safety Commission
Feb 17, 2026, 06:56 ET Genuine Parts Company Announces Plan to Separate Automotive and Industrial Businesses Into Two Industry-Leading Public Companies
serving as financial advisors to GPC, King & Spalding LLP is serving as legal counsel and Collected Strategies is serving as strategic communications advisor.Fourth Quarter and Full-Year 2025 Financial ResultsIn a separate press release issued today, GPC announced its financial results
More news about: Genuine Parts Company
Feb 17, 2026, 06:55 ET Genuine Parts Company Reports Fourth Quarter and Full-Year 2025 Results
advance our GPC strategies in 2025 while navigating a dynamic environment, thanks to the commitment of our teammates," said Will Stengel, Chair-Elect and Chief Executive Officer. "We stayed focused on what we can control, executing defined initiatives to deliver growth and improve productivity. As GPC has evolved
More news about: Genuine Parts Company
Jan 27, 2026, 08:30 ET Genuine Parts Company to Report Fourth Quarter and Full-Year 2025 Results on February 17, 2026
ATLANTA, Jan. 27, 2026 /PRNewswire/ -- Genuine Parts Company (NYSE: GPC), a leading global service provider of automotive and industrial replacement parts and value-added solutions, plans to release fourth quarter and full-year
More news about: Genuine Parts Company
Jan 22, 2026, 23:40 ET 晶泰科技賦能萊芒生物取得細胞療法重大成果，以1‰劑量CAR-T實現多位系統性紅斑狼瘡完全緩解出院
「門診制備」 的重要跨越。除血液瘤與自身免疫性疾病外，萊芒生物正將 META 10 平台拓展至實體瘤等領域。針對宮頸癌、肝癌、膽管癌等實體瘤適應症的代謝增強型細胞療法已經進入 IIT 臨床研究階段，正在進行患者招募和入組治療。針對 EGFR vIII 陽性膠質母細胞瘤與 GPC3 陽性肝細胞癌的 IL-10 CAR-T 療法已進入 IIT 臨床準備階段，預計 2026 年第一季度啟動 IIT 臨床研究。值得一提的是，萊芒生物的 META 10 技術平台具有高度兼容性，不僅適用於自體 CAR-T，還可拓展至 in vivo CAR-T、TCR-T、TILs 等多種細胞治療形式，具備為合作夥伴提供即插即用解決方案的潛力。這種技術的靈活性與可擴展性使其成為細胞治療領域的
More news about: 晶泰科技
Jan 18, 2026, 19:30 ET AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
entitled to receive up to $630 million from AstraZeneca including an upfront payment, and development, regulatory and sales milestone payments for the GPC3 program in China.
More news about: AbelZeta Pharma, Inc.
Jan 15, 2026, 08:30 ET Genuine Parts Company Announces Board Leadership Transition
extraordinary service to GPC," said P. Russell Hardin, lead independent director. "Paul has served the company with distinction for more than two decades, successfully streamlining GPC's portfolio and strengthening governance while upholding the values and principles that have made GPC successful for almost
More news about: Genuine Parts Company
Jan 12, 2026, 20:44 ET Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
manufacturingOricell has generated proof-of-concept (POC) clinical data across multiple pipeline CAR-T products. Its lead program, Ori-C101, is an autologous GPC3-targeted CAR-T therapy for advanced hepatocellular carcinoma (HCC). Both a Phase I Investigator-Initiated Trial (IIT) and a Phase I IND study of Ori-C101
More news about: OriCell Therapeutics Co., Ltd.